Sheri Tarr is uniquely positioned at the intersection of compliance, commercialization, and life sciences. A former pharmaceutical industry sales and marketing executive turned litigator who held pharmaceutical companies accountable for deceptive marketing and defective manufacturing, ten years ago Sheri founded ’68PARTNERS, a commercialization and compliance consultancy dedicated to helping life sciences, hemp, and cannabis stakeholders build sustainable businesses that improve the quality of peoples’ lives.
Sheri has amassed nearly 30 years of real-world experience with all aspects of branding and commercializing products in a regulated environment. She has a deep understanding of the complex business and legal challenges faced by life sciences decision-makers, and has also seen first-hand the adverse consequences to companies and patients that result from a misalignment of these priorities. A strong proponent of the consumer’s right to safe and effective products, in her consulting practice Sheri helps companies create practical commercialization and compliance strategies that balance business objectives with foreseeable risk, so that patients and consumers reap the benefits of life-changing products.
A University of Michigan alum and Chicago-Kent College of Law graduate, Sheri serves on the Boards of emerging life sciences companies, volunteers as a commercial strategist for a Haitian enterprise that empowers local entrepreneurs and is a long-time voting rights advocate.